Sign in

NCT04499898RecruitingPhase 2/3

Carvedilol Versus Endoscopic Band Ligation for Primary Prophylaxis of Oesophageal Variceal Bleeding

Randomized Controlled Trial of Carvedilol Versus Endoscopic Band Ligation for Primary Prophylaxis of Oesophageal Variceal Bleeding in Cirrhotic Patients With Arterial Hypertension

Source: ClinicalTrials.gov · Last updated 5 Aug 2020 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

Carvedilol versus endoscopic band ligation for primary prophylaxis of oesophageal variceal bleeding in cirrhotic patients with arterial hypertension

Status (registry)
Recruiting
Phase (registry)
Phase 2/3
Study type
Interventional
Enrollment
306 (estimated)
First submitted
1 Aug 2020
Start date
1 Oct 2018
Primary completion date
1 Dec 2030
Lead sponsor
Sherief Abd-Elsalam
NCT number
NCT04499898

What you commit to

  • Study type: Interventional · Phase 2/3
  • Planned participants: 306
  • From 1 Oct 2018 to the primary completion date, 1 Dec 2030
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • • History of variceal bleeding or previous primary prevention of varices.
    • Portal vein thrombosis or previous porto-systemic shunts as TIPS.
    • Patients on drugs affecting portal pressure (beta blockers, nitrates).
    • Advanced cardiovascular disease including acute myocardial infarction, atrio-ventricular block, congestive heart failure, chronic peripheral ischemia, severe bradycardia.
    • Patients with severe respiratory diseases (COPD, bronchial asthma).
    • Uncontrolled diabetes mellitus
    • Renal impairment
    • Hepatocellular carcinoma
    • Allergy to carvedilol
    • Pregnancy or lactation

Who the study is looking for

  • • Aged \>18 years
    • Cirrhotic patients with arterial hypertension
    • Endoscopic evidence of medium/large-sized esophageal varices

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Sherief Abd-Elsalam
Coordinator of this site? Confirm its status
TantaEgyptRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.